Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
about
Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and CancerTherapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.A CYP26B1 polymorphism enhances retinoic acid catabolism and may aggravate atherosclerosis.Psoriasis care: new and emerging pharmacologic trends.Current investigational drugs in psoriasis.Inhibition of the all-trans Retinoic Acid (atRA) Hydroxylases CYP26A1 and CYP26B1 Results in Dynamic, Tissue-Specific Changes in Endogenous atRA Signaling.Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice.Local skin pharmacokinetics of talarozole, a new retinoic acid metabolism-blocking agent.Emerging drugs for psoriasisImidazoles as potential anticancer agents
P2860
Q26800202-A052FFF2-013C-4C1D-9239-B6D12F684728Q34345596-04554789-279E-47F6-A841-5CE800BEC12CQ36071717-4CAC1ACF-9666-486C-BAE7-72B9E83401B6Q37757329-5F7468B4-57B6-4FC9-8CDE-EF044C31E3CFQ37991748-3DFCD23F-859E-44EA-B156-C9C7F77A1FFFQ38818104-24A7713E-4E5F-4615-9539-D3444F5C84A6Q43139949-105EDC98-7537-405D-B691-BEAC580316F1Q44662078-E7BBB600-C955-4BCB-BB49-D201C99D12D8Q57244448-646EA20B-79E4-43C3-B6F0-4ACA534C8245Q59149996-ABCDB1A5-2E79-4A75-895B-368C7B077E5B
P2860
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
@en
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
@nl
type
label
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
@en
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
@nl
prefLabel
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
@en
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
@nl
P2093
P2860
P1476
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
@en
P2093
Bovenschen HJ
Steijlen PM
Thissen CA
Verfaille CJ
van de Kerkhof PC
P2860
P304
P356
10.1111/J.1468-3083.2007.02158.X
P577
2007-09-01T00:00:00Z